Smoking bans were tied to a decrease in health problems and deaths - especially those related to heart disease, researchers report in the journal Cochrane Library.
"I think the bans benefit everybody through a reduction of secondhand smoke exposure," said senior author Cecily Kelleher, of University College Dublin in Ireland.
Also Read
Tobacco is currently responsible for the death of about one in every 10 adults around the world, the researchers write. They did their analysis for the Cochrane Collaboration, which is known for reviewing medical evidence and determining its quality.
A previous Cochrane review found that smoking bans reduced people's exposure to secondhand smoke, but back then the reviewers weren't able to show that decreased smoke exposure led to better health.
"We undertook the original review in 2010, and the evidence base was nothing like the evidence now," said Kelleher.
This time, the researchers specifically included studies that looked beyond secondhand smoke exposure. For example, they looked in medical databases for studies examining links between smoking bans and rates of heart attacks, strokes, respiratory problems, infant health and deaths.
Ultimately, they included 77 studies from 21 countries. Many of the studies used data from hospitals, national health registries and workplaces.
Forty-three studies specifically examined heart attacks and acute coronary syndrome. Thirty-three of the papers found a link between introducing smoking bans and a decrease in those events.
Of the six studies that examined the link between strokes and smoking bans, five found benefits.
For example, a study from Ireland reported a 26 per cent fall in deaths from heart disease and a 32 per cent decrease in stroke deaths.
The reviewers also found evidence that the smoking bans were beneficial to respiratory and newborn health. The quality of evidence behind those findings were very low, however.
"These are persuasive that these bans are beneficial," Kelleher said of the results.
She added, however, that better and more uniform research is needed to strengthen the evidence behind these benefits.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)